Oncternal Therapeutics Inc
(ONCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,627 | 11,178 | 22,432 | 14,529 | 19,283 |
| Marketable Securities | 1,915 | 6,080 | 5,345 | 200 | 1,675 |
| TOTAL | $12,461 | $18,452 | $29,055 | $15,171 | $21,788 |
| Non-Current Assets | |||||
| PPE Net | 42 | 58 | 86 | 112 | 217 |
| Intangibles | 513 | 625 | 652 | 322 | 487 |
| TOTAL | $555 | $683 | $738 | $434 | $704 |
| Total Assets | $13,016 | $19,135 | $29,793 | $15,605 | $22,492 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 179 | 992 | 619 | 808 | 1,253 |
| Accrued Expenses | 2,139 | 2,711 | 3,894 | 3,759 | 3,912 |
| TOTAL | $2,318 | $3,703 | $4,513 | $4,567 | $5,165 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 82 | 147 | 195 | 354 | 389 |
| TOTAL | $82 | $147 | $195 | $354 | $389 |
| Total Liabilities | $2,400 | $3,850 | $4,708 | $4,921 | $5,554 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 54 | 54 | 54 | 54 | 45 |
| Common Shares | 76 | 76 | 75 | 63 | 63 |
| Retained earnings | -480,226 | -475,291 | -464,347 | -455,360 | -447,570 |
| TOTAL | $10,616 | $15,285 | $25,085 | $10,684 | $16,938 |
| Total Liabilities And Equity | $13,016 | $19,135 | $29,793 | $15,605 | $22,492 |